Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine whether treating head injured patients with valproate sodium will
reduce the risk of developing seizures as a result of the head injury.
II. Determine the safety of valproate, the appropriate dose, and the effect valproate may
have on the recovery of the brain's ability to compute numbers, solve problems, remember
information, and control the movement of limbs after head injury.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)